Italian pharmaceutical and diagnostics company Menarini Group has signed a definitive agreement to acquire US-based Stemline Therapeutics for up to $677m.
United in the fight against Covid-19. In a difficult time for Italy and the entire world, pharmaceutical company Menarini Group is taking healthcare professionals and patient health even more to heart.